News

Preeclampsia Risk and Early Pregnancy Homocysteine Levels: The Protective Role of 6S-5-Methyltetrahydrofolate
Preeclampsia, a condition unique to pregnancy, affects 5-10% of expecting mothers and is a significant threat to both maternal and fetal health, being a leading cause of maternal and perinatal mortality. Recent studies have revealed a strong correlation between homocysteine (HCY) levels in early pregnancy and the risk of developing preeclampsia.
Learn More
The Impact of MTHFR Gene Polymorphisms on Folate Metabolism and Preeclampsia Risk
Preeclampsia, a complex disorder unique to pregnancy, is characterized by high blood pressure and proteinuria, typically emerging after the 20th week of gestation. It poses significant risks to both the mother and the fetus. While the exact etiology remains elusive, it is believed to involve genetic, immunological, and endothelial dysfunction factors.
Learn More
Preeclampsia and Folate: The Potential of 5-Methyltetrahydrofolate (5-MTHF) in Preeclampsia Prevention
Preeclampsia, a stealthy threat during pregnancy, has long been a source of concern for countless families. It poses a risk to both maternal health and fetal development. In the quest for effective preventative measures, the medical community has made significant strides with a recent discovery—5-Methyltetrahydrofolate (5-MTHF).
Learn More
October 30-31 | SupplySide West 2024 | Magnafolate
Welcome to our Booth 3056 @SupplySide West 2024| Oct 30-Oct 31 in Las Vegas, NV. We look forward to meeting you and showcasing our innovative folate product, Magnafolate.
Learn More
BMJ Study: High-Dose Folic Acid Fails to Lower Preeclampsia Risk
Preeclampsia is a grave pregnancy complication that poses a significant threat to the health of expecting mothers worldwide. It is a contributing factor to premature births, increased perinatal health issues, mortality rates, and long-term disabilities.
Learn More
Safeguarding Maternal and Infant Health: The Role of 5-Methyltetrahydrofolate (5-MTHF) in Preeclampsia Prevention
Preeclampsia is a pregnancy-specific disorder, affecting 5% to 10% of all pregnancies, and is a significant contributor to maternal and perinatal mortality rates. Characterized by high blood pressure and proteinuria, it can lead to severe complications such as organ dysfunction, restricted fetal growth, and premature birth.
Learn More

<...56789...89>

Latest Products

About US

Featured News

Dr. Lian Zengli Takes on Committee Role at Women and Children's Health Conference

Safeguarding Pregnancy Health: How Naturalization Folate Helps Prevent Preeclampsia

Featured News

Dr. Lian Zengli Takes on Committee Role at Women and Children's Health Conference

Safeguarding Pregnancy Health: How Naturalization Folate Helps Prevent Preeclampsia

Consulting Service

If you have any questions, please contact us!

Preeclampsia Risk and Early Pregnancy Homocysteine Levels: The Protective Role of 6S-5-Methyltetrahydrofolate

Learn More

The Impact of MTHFR Gene Polymorphisms on Folate Metabolism and Preeclampsia Risk

Learn More

Preeclampsia and Folate: The Potential of 5-Methyltetrahydrofolate (5-MTHF) in Preeclampsia Prevention

Learn More

October 30-31 | SupplySide West 2024 | Magnafolate

Learn More

BMJ Study: High-Dose Folic Acid Fails to Lower Preeclampsia Risk

Learn More

Safeguarding Maternal and Infant Health: The Role of 5-Methyltetrahydrofolate (5-MTHF) in Preeclampsia Prevention

Learn More

Let's talk

We're Here to Help

Contact Us

Magnafolate®

About US

Knowledge of L-methylfolate

Subscribe

Latest News

Online Service